Aging
Conditions
Keywords
Aging, Drug-related problems, Medication review, Community pharmacist, Medication use
Brief summary
In this intervention study, 75 Belgian community pharmacies each recruit 12 patients for an intermediate medication review. For each patient, the identified drug-related problems and subsequent interventions are registered using the PharmDisc classification. In a subset of Dutch speaking patients, a pretest-posttest single group design is used to measure the impact of this review on patient related outcomes using questionnaires. The primary outcome is the medication related quality of life, measured via the living with medicines questionnaire. Other patient reported outcomes include adherence, self-management, patient satisfaction, fall incidents and use of emergency healthcare services. Medication records are also collected to objectively measure adherence before and after the intervention.
Interventions
The intervention consists of a medicines use review provided by community pharmacists in Belgium. A medicines use review is a medication review type 2a in which both a patient interview and dispensing data are used as information sources to identify drug-related problems with a specific focus on the medicines use of the patient.
Pre-post study design. At three timepoints, data is collected: * before the medication review (T-1week) * during the review (Tweek 3) * after the review (Tweek12) The questionnaire provide data for the outcomes: medication related quality of life, adherence questionnaire, service satisfaction, use of emergency health services, self-management
Sponsors
Study design
Intervention model description
Parallel group intervention study. In a subset of 140 patients, a pre-post study design is used.
Eligibility
Inclusion criteria
* Patients should be 70 years or older * Use five or more drugs on a regular basis (prescription or non-prescription drugs) * Live in the ambulatory setting * Obtain his medication from this pharmacy on a regular basis
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Drug-related problems & interventions | One timeframe: during the medication review | Using the validated PharmDisc classification tool |
| Change in medication related quality of life | Three timepoints: Before the review, during review (week 3), after the review (week 12) | using the Living with medicines questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in adherence | 9 months before and after the intervention | using dispensing data |
| Change in self-management | Two timepoints: Before the review, after the review (week 12) | using the PAM questionnaire |
| Change in use of emergency healthcare services & fall incidents | Two timepoints: Before the review, after the review (week 12) | using own questions |
| Satisfaction with the new service | One timepoint: during the review (week 3) | Using the PSPSQ2 questionnaire |